Innovation in Vaccinology

Preface.- Section I Vaccine design.- 1. Design of new vaccines in the genomic and post-genomic era, Laura Serino, Kate L. Seib and Mariagrazia Pizza.- 2. Comparing in silico results to in vivo and ex vivo of influenza-specific immune responses after vaccination or infection in humans, Filippo Castiglione, Benjamin Ribba and Olivier Brass.- Section II Vaccine delivery.- 3. Vaccine glycoprotein tagged with the human Fc domain as second generation vaccine candidates, Silvia Loureiro, Elena Robinson, Hongying Chen, Pongsathon Phapugrangkul, Camilo Colaco and Ian M Jones.- 4. Engineered viruses as vaccine platforms, Antonella Folgori and Stefania Capone.- 5. Virus-like particles as efficient delivery platform to induce a potent immune response, Fabien Rebeaud and Martin Bachmann.- 6. Filamentous bacteriophages: an antigen and gene delivery system, Rossella Sartorius, Domenico Russo, Luciana D'Apice and Piergiuseppe De Berardinis.- 7. Liposomes and other nanoparticles as cancer vaccines and immunotherapeutics, Joseph J. Altin.- 8. Plant-based vaccine delivery strategies, Chiara Lico, Carla Marusic, Floriana Capuano, Giampaolo Buriani, Eugenio Benvenuto, Selene Baschieri.- 9. TLR agonists as vaccine adjuvants, Mark A. Tomai and John P. Vasilakos.-10. Mucosal vaccines for enteric bacterial pathogens, Paolo Pasquali.- Section III Pre-clinical vaccine testing.- 11. The importance of animal models in the development of vaccines, Tadele G. Kiros, Benoit Levast, Gael Auray, Stacy Strom, Jill van Kessel and Volker Gerdts.- 12. Correlates of vaccine-induced immunity: historical perspectives and future challenges, Ian J. Amanna.- Index.